Tomiki Sumiyoshi
Dr. Sumiyoshi obtained his MD and PhD at Kanazawa University, Japan, and is currently Clinical Professor and Director of Translational Research at the Department of Neuropsychiatry, University of Toyama Graduate School of Medicine and Pharmaceutical Sciences. He was trained at the Department of Psychiatry Case Western Reserve University as Research Associate from 1993 to 1995, and was appointed Visiting Professor in the Department of Psychiatry, Vanderbilt University from 2000 to 2002, as the founder of the augmentation pharmacotherapy to ameliorate cognitive impairment of schizophrenia. His research fields include cognitive neuroscience and psychopharmacology, as represented by more than 100 peer-reviewed articles and book chapters. Dr. Sumiyoshi is an Editorial Board member of Psychiatry Journal, and Co-Chair of Psychoneurobiology Section of World Psychiatric Association.